Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems Human Fc Gamma RIIIA/CD16a Protein, V176, His Tag, 100 μg

Catalog No. 501017439
Encompass_Preferred

This recombinant Human Fc gamma RIIIA (CD16a, V176) protein is an intermediate-affinity, polypeptide-anchored transmembrane glycoprotein expressed in human HEK293 cells. It serves as a receptor for the Fc portion of IgG antibodies and plays a critical role in immunological processes, including phagocytosis, secretion of inflammatory mediators, and antibody-dependent cytotoxicity. The protein contains a C-terminal polyhistidine tag and has a calculated molecular weight of 23.7 kDa, migrating at 40–60 kDa in SDS-PAGE due to glycosylation.

  • Expressed in human HEK293 cells for appropriate post-translational modifications
  • Purity >95% as determined by SDS-PAGE and SEC-MALS
  • Lyophilized in PBS, pH 7.4, with trehalose protectant
  • Endotoxin level <1.0 EU per μg by LAL method
  • Validated for binding applications using SPR and BLI

Catalog No. 50-101-7439 Supplier ACROBiosystems Supplier No. CD8H52H4100UG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

This recombinant Human Fc gamma RIIIA (CD16a, V176) protein is an intermediate-affinity, polypeptide-anchored transmembrane glycoprotein expressed in human HEK293 cells. It serves as a receptor for the Fc portion of IgG antibodies and plays a critical role in immunological processes, including phagocytosis, secretion of inflammatory mediators, and antibody-dependent cytotoxicity. The protein contains a C-terminal polyhistidine tag and has a calculated molecular weight of 23.7 kDa, migrating at 40–60 kDa in SDS-PAGE due to glycosylation.

  • Expressed in human HEK293 cells for appropriate post-translational modifications
  • Purity >95% as determined by SDS-PAGE and SEC-MALS
  • Lyophilized in PBS, pH 7.4, with trehalose protectant
  • Endotoxin level <1.0 EU per μg by LAL method
  • Validated for binding applications using SPR and BLI

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.